NCT01502085 2026-04-03
RZD
Hackensack Meridian Health
Phase 1/2 Completed
Clinical Trials
4 trialsNCT01522976 2026-03-31
Azacitidine With or Without Lenalidomide or Vorinostat in Treating Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
National Cancer Institute (NCI)
Phase 2 Active not recruiting
NCT00616967 2026-03-05
Carboplatin and Nab-Paclitaxel With or Without Vorinostat in Treating Women With Newly Diagnosed Operable Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Active not recruiting
NCT00875056 2026-01-30
MK-0683-103
Merck Sharp & Dohme LLC
Phase 2 Completed